Home / Markets / News / Pharma funds lag sectoral peers despite Covid tailwind as US market weighs

Pharma funds lag sectoral peers despite Covid tailwind as US market weighs

In the year to date, the Nifty pharma index has returned 8.8 per cent, with 10 of its constituents giving negative returns

Premium

3 min read Last Updated : Nov 02 2021 | 1:49 AM IST

Pharma funds have remained laggards among sectoral funds despite a sharp rally in pharma stocks last year in the aftermath of the Covid-19 outbreak.

These funds have shed 3 per cent during the last three months and have gained 29 per cent in a year even as the NSE Nifty Pharma index has shed 2.6 per cent and gained 25 per cent. In comparison, the Nifty 50 index has gained 12 per cent and 51 per cent, respectively. In the year to date, the Nifty pharma index has returned 8.8 per cent, with 10 of its constituents giving negative returns.

Topics : Pharma stocks Pharma sector Pharma funds performance

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in